Agios Pharmaceuticals Claimed Company
Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism. read more
HR or Marketing? Claim Your Free Employer Account
Christopher Bowden M.D. ā Chief Medical Officer at Agios Pharmaceuticals
Executive Bio
Dr. Christopher Bowden, also known as Chris, M.D. has been the Chief Medical Officer of Agios Pharmaceuticals, Inc. since May 14, 2014. Dr. Bowden served as Vice President of Product Development for Clinical Oncology, Franchise lead (Signaling Group) at Genentech Inc., a member of the Roche Group. He has more than 17 years of experience in clinical drug development, including the approval of several cancer medicines During Dr. Bowden's eight years at Genentech, he was responsible for the successful development of a number of novel oncology medicines. He led the teams responsible for the development and global registrations of several marketed cancer medicines, including Zelboraf(R) indicated for the treatment of BRAF V600E mutant-positive metastatic melanoma, Tarceva(R) indicated for the first line therapy of patients with non-small cell lung cancer whose tumors have an activating mutation of the Epidermal Growth Factor receptor (EGFR), and Erivedge(R) for patients with unresectable, locally advanced or metastatic basal cell carcinoma. From 2003 to 2006, Dr. Bowden was the Executive Director for EMEA (Europe, Middle East, Africa) regions for Bristol-Myers Squibb. In this role, he led medical affairs strategies for cancer, immunology and pain medicines. Earlier, Dr. Bowden held positions of increasing responsibility in oncology clinical development, Phases I-III, at Pharmacia Corporation and Janssen Pharmaceutica. Prior to his industry experience, Dr. Bowden was on the oncology faculty at the University of Virginia Health Science Center where he participated in numerous industry and cooperative group trials. He has been a Director of Miragen Therapeutics, Inc. since August 10, 2017. Dr. Bowden received his medical degree from Hahnemann University School of Medicine in Philadelphia followed by internal medicine training at Roger Williams Medical Center and the Providence VA Medical Center, Rhode Island. He completed his medical oncology fellowship at the National Cancer Institute Medicine Branch. Dr. Bowden is board certified in internal medicine and medical oncology.
Key Executives
Name
Title
Salary
Total Comp Total Compensation includes both short-term and long-term benefits, option grants, salary, bonuses, company perks, etc. that can be used to determine financial benefits. An executive may or may not realize all of the Total Co mpensation during their tenure at the Company. Values of the benefits may change over time.
Executive Team Culture Ratings from Agios Pharmaceuticals Employees
BOTTOM
10%
Agios Pharmaceuticals' Executive Team scores in the Bottom 10%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at Agios PharmaceuticalsNot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at Agios PharmaceuticalsAgios Pharmaceuticals' Executive Team at a Glance
Based on 6 ratings, Agios Pharmaceuticals' employees are less satisfied with their Executive Team and give them a āD-ā or 49/100.
Agios Pharmaceuticals' Executive Team ranks in the Bottom 10% of other companies in Boston and Bottom 10% of other companies on Comparably that also have 51-200 Employees.
×